Fig. 9From: Preparation of a camptothecin analog FLQY2 self-micelle solid dispersion with improved solubility and bioavailabilityIn vivo anticancer efficiency of FLQY2 (1.5 mpk, p.o./QW), FLQY2 (1 mpk, p.o./QW), Irinotecan hydrochloride (100 mpk, i.p./QW), Paclitaxel-albumin (15 mpk, i.v./Q4D) and saline (p.o.): A mean tumor volume, B weight change rate, C average tumor weight, and D photo of resected tumorsBack to article page